Blog
RSS FeedPosted by Michael Wonder on 02 Mar 2023
PHARMAC confirms widened access for the funded flu vaccine
2 March 2023 - PHARMAC is widening access to the annual funded flu vaccine to tamariki aged 6 months to 12 ...
Posted by Michael Wonder on 28 Feb 2023
PHARMAC will fund meningococcal B vaccine for babies, teens and young people
28 February 2023 - From Wendesday, PHARMAC will fund meningococcal B vaccine for a number of potentially at-risk groups including ...
Posted by Michael Wonder on 08 Feb 2023
All adults now eligible for a 2023 COVID-19 booster dose
8 February 2023 - The Australian Government has accepted advice from the Australian Technical Advisory Group on Immunisation that all adults ...
Posted by Michael Wonder on 06 Feb 2023
Changes to HPV vaccine dose schedule for young Australians
6 February 2023 - From 6 February 2023 the human papillomavirus vaccine schedule will become a single dose schedule. ...
Posted by Michael Wonder on 29 Jan 2023
Government must place a higher value on vaccines and medicines that deliver long term benefits
30 January 2023 - Medicines Australia has used its budget submission to remind Government of its commitment to lower Australia’s ...
Posted by Michael Wonder on 19 Dec 2022
New report indicates COVID-19 vaccines saved Australia’s economy
19 December 2022 - Medicines Australia welcomes the latest peer-reviewed research paper indicating the rollout of the COVID-19 vaccinations significantly ...
Posted by Michael Wonder on 11 Dec 2022
Lives will continue to be lost to meningococcal disease as PHARMAC funding for vaccines does not go far enough
8 December 2022 - Meningitis Foundation says PHARMAC must make both the meningococcal B and ACWY vaccines available to all ...
Posted by Michael Wonder on 21 Nov 2022
'Heartbreaking': parents of sick 11 month old want greater meningitis awareness
19 November 2022 - A cough quickly turned into a “horrible” few weeks for an Auckland family whose infant son ...
Posted by Michael Wonder on 17 Nov 2022
New COVID-19 vaccines for eligible Australians
15 November 2022 - The Australian Government has accepted a recommendation from the Australian Technical Advisory Group on Immunisation (ATAGI) on ...
Posted by Michael Wonder on 15 Nov 2022
Expansion of access to MenB vaccine urgently needed
15 November 2022 - Meningococcal B is a rare but very serious disease, causing death and serious long-term disabilities. Even when ...
Posted by Michael Wonder on 07 Nov 2022
PHARMAC widens access to pneumococcal vaccine
7 November 2022 - PHARMAC has announced today that all young tamariki will receive access to the PCV13 pneumococcal vaccine (Prevenar ...
Posted by Michael Wonder on 26 Oct 2022
The Meningitis Foundation says PHARMAC proposal to partially fund a meningococcal B vaccine will not work
26 October 2022 - Meningitis Foundation says Pharmac must make vaccine available to all young people, not just those in ...
Posted by Michael Wonder on 25 Oct 2022
PHARMAC to consider funding the Meningococcal B vaccine but concerns remain
26 October 2022 - PHARMAC has confirmed it will consider funding the Meningococcal B vaccine, which is a crucial tool ...
Posted by Michael Wonder on 25 Oct 2022
PHARMAC considers funding meningococcal B vaccine to be part of childhood immunisations
26 October 2022 - PHARMAC today has announced a consultation on widening access to the meningococcal B vaccine (branded as Bexsero), ...
Posted by Michael Wonder on 11 Oct 2022
Nearly a fifth of Australia’s Covid vaccine stock binned amid warning of fresh wave of cases
11 October 2022 - Dwindling demand for booster shots causes concern immunisation gaps leaving country open to new variants. ...